Immunology Laboratory


KEY FACULTY

Patrizio P. Caturegli, MD, MPH

Patrizio P. Caturegli, M.D., M.P.H.
Director, Immunology Division
Director, Clinical Immunology Laboratory
Director, Autoimmune Disease Research Center
Professor of Pathology

The Johns Hopkins Hospital
1800 Orleans St.
Sheikh Zayed Tower
Baltimore, MD 21287

Dr. Patrizio P. Caturegli is a Professor of Pathology, Endocrinology, and Immunology at the Johns Hopkins University Schools of Medicine and Public Health. He is the Director of the Immunology Division of the Department of Pathology, the Director of the Clinical Immunology Laboratory of the Johns Hopkins Medical Institutions, and the Director of the Autoimmune Disease Research Center, which is housed in the department of Pathology. In December 2018, Dr. Caturegli was also named the first Patrizio Caturegli Professor, MD MPH of Immunopathology by the President of the Johns Hopkins University.

Dr. Caturegli earned his medical degree from the Faculty of Medicine and Surgery of the University of Pisa, Italy, where he also completed a residency in endocrinology under professor Aldo Pinchera. Dr. Caturegli then came to Johns Hopkins in 1993 where he did a fellowship in immunology in Dr. Noel Rose's laboratory, a residency in pathology, and a Master of Public Health. He joined the faculty of the Department of Pathology in July 1998 and was board certified by the American Board of Pathology in 1999.

Dr. Caturegli's clinical and research work focuses on autoimmune diseases of the endocrine glands, in particular those of the thyroid and pituitary gland. He has published over 120 articles.



Daniela Cihakova, MD, PhD

Daniela Ciháková, M.D., Ph.D.
Associate Director, Clinical Immunology Laboratory
Associate Professor of Pathology

Dr. Daniela Ciháková is an Associate Professor of Pathology at the Johns Hopkins University School of Medicine. She also has a joint appointment in the Department of Molecular Microbiology and Immunology. Dr. Ciháková is an American Board of Medical Laboratory Immunology (ABMLI) certified clinical laboratory immunologist and an Associate Director of Immunology Clinical Laboratory at Johns Hopkins University.

Her research focuses on the cardiac immunology and understanding how immune cells and cardiac stromal cells contribute to the pathogenesis of various cardiovascular diseases such as myocarditis, dilated cardiomyopathy, pericarditis, myocardial infarction or check point inhibitors induced cardiac inflammation and congenital complete heart block. She also studies autoimmune disorders such as Sjögren's syndrome, rheumatoid arthritis and gluten associated diseases in schizophrenia.

Dr. Ciháková earned her M.D. and Ph.D. from Charles University in Prague, Czech Republic. She completed her postdoctoral fellowship at Johns Hopkins University in 2006. Dr. Ciháková joined the Johns Hopkins faculty in 2008.

Dr. Ciháková research has been supported by the NIH/NHBLI, American Heart Association, Children's Cardiomyopathy Foundation, W.W. Smith Charitable Trust, Mirowski Discovery Award, National Organization for Rare Diseases, American Autoimmune Related Disease Association (AARDA), Sjögrens syndrome Foundation, Matthew Poyner MVP Memorial Myocarditis Research Foundation and Myocarditis Foundation.



Maxim Rosario, M.B., B.Ch., B.A.O., D.Phil

Maxim Rosario, M.B., B.Ch., B.A.O., D.Phil
Associate Director, Clinical Immunology Laboratory
Assistant Professor of Pathology

Johns Hopkins School of Medicine
720 Rutland Street 659b
Baltimore, MD

Dr. Rosario completed his medical education at University College Cork in Ireland. He then pursued an M.Sc. in integrated immunology at the John Radcliff Hospital, and his D. Phil (Ph.D.) in HIV-1 vaccinology at the Weatherall Institute of Molecular Medicine (WIMM), University of Oxford, England. He was a postdoctoral fellow at the Li Ka Shing Institute of Virology (University of Alberta) in Edmonton, and then moved to Washington University in St. Louis for a clinical pathology residency. After completing his residency, he moved to UCLA for a fellowship in clinical immunogenetics. Max's clinical contribution will focus on immunopathology. He has a keen interest in translational research related to cell mediated pathology. He hopes to further immunotherapy for leukemia and lymphoma by harnessing the potency of NK cells to kill malignant cells. He is also interested in T-cell immunology as related to vaccinology and transplant pathology.


▲top